scholarly article | Q13442814 |
P50 | author | Paul De Sousa | Q38360854 |
Stephen Pells | Q42802376 | ||
Mark W Head | Q55300123 | ||
Jean C Manson | Q56449149 | ||
Zuzana Krejciova | Q117221975 | ||
Enrico Cancellotti | Q117221979 | ||
James Ironside | Q29643044 | ||
P2093 | author name string | Matthew Bishop | |
G Robin Barclay | |||
Kay Samuel | |||
Marc L Turner | |||
Paz Freile | |||
P2860 | cites work | Prion-like disorders: blurring the divide between transmissibility and infectivity | Q39863503 |
Variations in humanized and defined culture conditions supporting derivation of new human embryonic stem cell lines | Q40188775 | ||
Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. | Q40305663 | ||
Clinically failed eggs as a source of normal human embryo stem cells | Q42811221 | ||
Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia | Q43195687 | ||
Predicting susceptibility and incubation time of human-to-human transmission of vCJD. | Q43220422 | ||
Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent | Q44592404 | ||
Prospective isolation and molecular characterization of hematopoietic stem cells with durable self-renewal potential | Q47985026 | ||
Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. | Q48340913 | ||
Insoluble aggregates and protease-resistant conformers of prion protein in uninfected human brains. | Q48417052 | ||
Neural stem cell model for prion propagation | Q48513161 | ||
Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. | Q51037857 | ||
The expression of prion protein (PrP(C)) in the megakaryocyte lineage. | Q54242297 | ||
Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal | Q24541459 | ||
A novel human disease with abnormal prion protein sensitive to protease | Q24648865 | ||
Shattuck lecture--neurodegenerative diseases and prions | Q28189500 | ||
Mice devoid of PrP are resistant to scrapie | Q28249108 | ||
A general model of prion strains and their pathogenicity | Q28256770 | ||
The expanding universe of prion diseases | Q33239695 | ||
PRNP variation in UK sporadic and variant Creutzfeldt Jakob disease highlights genetic risk factors and a novel non-synonymous polymorphism | Q33520832 | ||
Iatrogenic Creutzfeldt-Jakob disease at the millennium. | Q33924749 | ||
Kuru in the 21st century--an acquired human prion disease with very long incubation periods | Q33997105 | ||
Feeder-free growth of undifferentiated human embryonic stem cells | Q34093315 | ||
Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient | Q34339769 | ||
A new variant of Creutzfeldt-Jakob disease in the UK. | Q34374893 | ||
Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. | Q34403513 | ||
High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. | Q34699610 | ||
Prion infection of mouse neurospheres | Q34944193 | ||
Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease | Q35070708 | ||
Accumulation of prion protein in the brain that is not associated with transmissible disease | Q35721757 | ||
PrPc does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov cells | Q36099038 | ||
Diagnostic approaches for viruses and prions in stem cell banks | Q36354421 | ||
Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study | Q36588347 | ||
Prions and their partners in crime | Q36628157 | ||
Halting the spread of human prion disease--exceptional measures for an exceptional problem | Q36836191 | ||
Insights into prion strains and neurotoxicity | Q36856446 | ||
Acute cellular uptake of abnormal prion protein is cell type and scrapie-strain independent. | Q37039973 | ||
An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products | Q37307945 | ||
Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification | Q37411403 | ||
The genetics of prion diseases | Q37705846 | ||
P433 | issue | 5 | |
P921 | main subject | human embryonic stem cell | Q59626782 |
prion protein family | Q24724413 | ||
P304 | page(s) | 635-645 | |
P577 | publication date | 2011-02-21 | |
P1433 | published in | Journal of Pathology | Q400296 |
P1476 | title | Human embryonic stem cells rapidly take up and then clear exogenous human and animal prions in vitro. | |
P478 | volume | 223 |
Q37252741 | A specific population of abnormal prion protein aggregates is preferentially taken up by cells and disaggregated in a strain-dependent manner |
Q93005212 | All the Same? The Secret Life of Prion Strains within Their Target Cells |
Q38075119 | Human prion diseases: molecular, cellular and population biology |
Q46174770 | Human stem cell-derived astrocytes replicate human prions in a PRNP genotype-dependent manner |
Q37415409 | Human tonsil-derived follicular dendritic-like cells are refractory to human prion infection in vitro and traffic disease-associated prion protein to lysosomes |
Q48239641 | Quality Assured Characterization of Stem Cells for Safety in Banking for Clinical Application |
Q64463950 | Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies |
Q34391242 | The prion protein family: a view from the placenta |
Q34646980 | Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytes |
Search more.